Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

The COVID-19 pandemic accelerated the development of decentralized clinical trials (DCT). DCT’s are an important and pragmatic method for assessing health outcomes yet comprise only a minority of clinical trials, and few published methodologies exist. In this report, we detail the operational compon...

Full description

Bibliographic Details
Main Authors: Nandini Avula, Dustin Kakach, Christopher J. Tignanelli, David M. Liebovitz, Jacinda M. Nicklas, Kenneth Cohen, Michael A. Puskarich, Hrishikesh K. Belani, John B. Buse, Nichole R. Klatt, Blake Anderson, Amy B. Karger, Katrina M. Hartman, Barkha Patel, Sarah L. Fenno, Neha V. Reddy, Spencer M. Erickson, David R. Boulware, Thomas A. Murray, Carolyn T. Bramante, COVID-OUT Trial Team
Format: Article
Language:English
Published: Cambridge University Press 2023-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Decentralized clinical trial
trial design
covid
remote research
randomized controlled trial
Online Access:https://www.cambridge.org/core/product/identifier/S2059866123006684/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2059866123006684/type/journal_article

Similar Items